AIM
CORT icon

Aigen Investment Management’s Corcept Therapeutics CORT Stock Holding History

Aigen Investment Management’s Portfolio CORT Stock Details CORT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-18,292
Closed -$407K – 870
2023
Q2 		$407K Buy
+18,292
New +$421K 0.06% 400
2022
Q4 		– Sell
-11,677
Closed -$299K – 569
2022
Q3 		$299K Buy
+11,677
New +$312K 0.04% 401
2022
Q1 		– Sell
-10,128
Closed -$201K – 642
2021
Q4 		$201K Buy
+10,128
New +$205K 0.01% 932
2020
Q4 		– Sell
-83,599
Closed -$1.46M – 817
2020
Q3 		$1.46M Sell
83,599
-57,220
-41% -$912K 0.19% 168
2020
Q2 		$2.37M Buy
140,819
+123,703
+723% +$1.74M 0.3% 76
2020
Q1 		$204K Buy
+17,116
New +$212K 0.03% 706

Other funds holding CORT

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $2.82B AUM 21.61% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PA
Parallel Advisors San Francisco, California $5.55B AUM 17.89% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $12.2B AUM 12.45% 1-Year Est. Return